Movement disorders with cerebral toxoplasmosis and AIDS.
Movement disorders occur in some patients with cerebral toxoplasmosis with HIV-1 infection. Such movement disorders have not been described in patients with cerebral toxoplasmosis without HIV-1 infection. This report discusses their diagnostic features, aspects of management, and possible mechanisms underlying the pathogenesis of the movement disorders.
Nath
A
A
Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.
Hobson
D E
DE
Russell
A
A
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy; D000328:Adult; D001480:Basal Ganglia Diseases / Q000175:diagnosis* / Q000188:drug therapy; D002540:Cerebral Cortex / Q000187:drug effects; D002819:Chorea / Q000175:diagnosis* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D015497:HIV-1; D006801:Humans; D008297:Male; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016781:Toxoplasmosis, Cerebral / Q000175:diagnosis* / Q000188:drug therapy
D013411:Sulfadiazine; D011739:Pyrimethamine